Replies to post #10016 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

MNTA’s own PR on the ‘en banc’ denial: SCOTUS next…

http://finance.yahoo.com/news/u-court-appeals-denied-momenta-174130491.html

"…we plan to file a petition for certiorari, asking the Supreme Court to review this case," said Craig Wheeler, President and Chief Executive Officer of Momenta. "We strongly believe that the CAFC panel decision in this case finds no support in the statutory text of the safe harbor provision of the patent law, or in Supreme Court precedent, and a final decision upholding this case could have wide-ranging, negative effects on drug development."